Role of Rasontail matra basti in Anovulatory cycle

Randomised controlled clinical study of Rasontail basti in Anovulatory cycle(Abijotsarga) (WHO CLASS2 CLASSIFICATION)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030096

Enrollment

106

Registered

2020-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

Intervention1: Rason tail matra basti: 60 ml Rasontail matra basti will be given Aftrar emptying the bowel in the morning at 9 am from 5th day of menses till 10 days. for 3 months . Rrtaintion time o

Eligibility

Inclusion criteria

Inclusion criteria: 1.PCOD 2.Irregular menses /Scanty menses due to Anovulation 3.Anovulation/Oligoovulation 4.Delayed Ovulation

Exclusion criteria

Exclusion criteria: 1. Bleeding P/V 2.cervical polyp, tumour, Ca Cervix 3. Uterine Fibroid 4.Congenital anomalies in female genital tract 5. Tubercular Endometritis 6.HIV/ VDRL/ HbsAg positive 7.Malignant diseased patient and Cytotoxic patient 8.Patient with all systemic disorders

Design outcomes

Primary

Measure	Time frame
efficacy of Rasontail matrabsti in anovulatory cycle whether the development of follicle ovulatation occurs on folicilar studyTimepoint: for 3 month . from 5th day of menses for 10 days.	—

Secondary

Measure	Time frame
Dysmenorrhea scanty menses Regularization of cycleTimepoint: 3 month	—

Countries

India

Contacts

Public Contactdr seema mehere

YMT Ayurvedical college PG institute Kharghar

seema.mehre@gmail.com9930940403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026